Gonzalez-Angulo AM - Search Results

1

Utility of oncotype DX risk estimates in clinically intermediate risk hormone receptor-positive, HER2-normal, grade II, lymph node-negative breast cancers.

Kelly CM, Krishnamurthy S, Bianchini G, Litton JK, Gonzalez-Angulo AM, Hortobagyi GN, Pusztai L. Kelly CM, et al. Cancer. 2010 Nov 15;116(22):5161-7. doi: 10.1002/cncr.25269. Cancer. 2010. PMID: 20665886 Free article.

2

Lack of association between amplification of her-2 and response to preoperative taxanes in patients with breast carcinoma.

Gonzalez-Angulo AM, Krishnamurthy S, Yamamura Y, Broglio KR, Pusztai L, Buzdar AU, Hortobagyi GN, Esteva FJ. Gonzalez-Angulo AM, et al. Cancer. 2004 Jul 15;101(2):258-63. doi: 10.1002/cncr.20348. Cancer. 2004. PMID: 15241821 Free article.

3

Central nervous system metastases in patients with high-risk breast carcinoma after multimodality treatment.

Gonzalez-Angulo AM, Cristofanilli M, Strom EA, Buzdar AU, Kau SW, Broglio KR, Smith TL, Hortobagyi GN. Gonzalez-Angulo AM, et al. Cancer. 2004 Oct 15;101(8):1760-6. doi: 10.1002/cncr.20530. Cancer. 2004. PMID: 15386311 Free article.

4

Women age < or = 35 years with primary breast carcinoma: disease features at presentation.

Gonzalez-Angulo AM, Broglio K, Kau SW, Eralp Y, Erlichman J, Valero V, Theriault R, Booser D, Buzdar AU, Hortobagyi GN, Arun B. Gonzalez-Angulo AM, et al. Cancer. 2005 Jun 15;103(12):2466-72. doi: 10.1002/cncr.21070. Cancer. 2005. PMID: 15852360 Free article.

5

Adjuvant therapy with trastuzumab for HER-2/neu-positive breast cancer.

Gonzalez-Angulo AM, Hortobágyi GN, Esteva FJ. Gonzalez-Angulo AM, et al. Oncologist. 2006 Sep;11(8):857-67. doi: 10.1634/theoncologist.11-8-857. Oncologist. 2006. PMID: 16951389 Free article. Review.

6

HER2 expression and efficacy of preoperative paclitaxel/FAC chemotherapy in breast cancer.

Andre F, Mazouni C, Liedtke C, Kau SW, Frye D, Green M, Gonzalez-Angulo AM, Symmans WF, Hortobagyi GN, Pusztai L. Andre F, et al. Breast Cancer Res Treat. 2008 Mar;108(2):183-90. doi: 10.1007/s10549-007-9594-8. Epub 2007 Apr 28. Breast Cancer Res Treat. 2008. PMID: 17468948

7

Efficacy and safety of neoadjuvant trastuzumab combined with paclitaxel and epirubicin: a retrospective review of the M. D. Anderson experience.

Dawood S, Gonzalez-Angulo AM, Peintinger F, Broglio K, Symmans WF, Kau SW, Islam R, Hortobagyi GN, Buzdar AU. Dawood S, et al. Cancer. 2007 Sep 15;110(6):1195-200. doi: 10.1002/cncr.22895. Cancer. 2007. PMID: 17647266 Free article.

8

Multifocal breast cancer in women < or =35 years old.

Litton JK, Eralp Y, Gonzalez-Angulo AM, Broglio K, Uyei A, Hortobagyi GN, Arun B. Litton JK, et al. Cancer. 2007 Oct 1;110(7):1445-50. doi: 10.1002/cncr.22928. Cancer. 2007. PMID: 17676585 Free article.

9

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.

Liedtke C, Mazouni C, Hess KR, André F, Tordai A, Mejia JA, Symmans WF, Gonzalez-Angulo AM, Hennessy B, Green M, Cristofanilli M, Hortobagyi GN, Pusztai L. Liedtke C, et al. J Clin Oncol. 2008 Mar 10;26(8):1275-81. doi: 10.1200/JCO.2007.14.4147. Epub 2008 Feb 4. J Clin Oncol. 2008. PMID: 18250347

10

Prognostic significance of HER-2 status in women with inflammatory breast cancer.

Dawood S, Broglio K, Gong Y, Yang WT, Cristofanilli M, Kau SW, Meric-Bernstam F, Buchholz TA, Hortobagyi GN, Gonzalez-Angulo AM; Inflammatory Breast Cancer Research Group. Dawood S, et al. Cancer. 2008 May 1;112(9):1905-11. doi: 10.1002/cncr.23350. Cancer. 2008. PMID: 18300243 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

266 results

Search Page

Filters